ÂÜÀòÂÒÂ×

Arnaud Amzallag is an experienced scientific professional currently serving as a Scientific Associate Director and Senior Principal Scientist at Bristol Myers Squibb since April 2019, focusing on multiomics supervised analyses for patient stratification in solid tumors and drug resistance. Previously, Arnaud held roles such as Principal Scientist at PatientsLikeMe, where the objective was to integrate omics and phenodynamics for patient-centered health solutions, as well as Senior Bioinformatics Consultant at Karyopharm Therapeutics Inc., analyzing clinical trial data and performing biomarker identification. Arnaud's earlier positions include Senior Computational Biologist at Selventa, Research Fellow in Computational Biology and Pharmaco-genomics at Massachusetts General Hospital/Harvard Medical School, and Scientist at EPFL, alongside a doctoral background in biotechnology and biophysics of DNA from EPFL. Arnaud's diverse educational achievements also include Master's Degrees from the Weizmann Institute of Science and ENSIIE, along with a Master's in Multimédia and Architecture of Communication from Université Panthéon-Assas.